Related Experiment Videos
Single-dose ceftriaxone versus 10 days of cefaclor for otitis media
J M Chamberlain1, D A Boenning, Y Waisman
1Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.
Insights
A single intramuscular dose of ceftriaxone effectively treats acute otitis media in children, showing comparable results to a 10-day oral cefaclor regimen. This single-dose antibiotic offers a convenient and effective treatment option for this common childhood infection.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Acute otitis media (AOM) is a common childhood infection.
- Current standard treatment involves multiple days of oral antibiotics, posing challenges with adherence.
- Exploring alternative, effective antibiotic regimens is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of a single intramuscular dose of ceftriaxone for treating AOM in children.
- To compare the effectiveness of single-dose ceftriaxone with a 10-day course of oral cefaclor.
Main Methods:
- A controlled clinical trial was performed with 54 children (18 months to 6 years) diagnosed with AOM.
- Participants were randomized to receive either a single intramuscular dose of ceftriaxone (50 mg/kg) or 10 days of oral cefaclor (40 mg/kg/day).
- Outcomes were assessed by symptom resolution and clinical/tympanometric evaluation of the tympanic membrane.
Main Results:
- No treatment failures were observed in either the ceftriaxone or cefaclor groups.
- Thirty-one children received ceftriaxone, and 23 received cefaclor.
- There were no statistically significant differences in the persistence of middle ear effusion or recurrence of AOM between the two treatment groups.
Conclusions:
- Single-dose intramuscular ceftriaxone is a favorable alternative to 10-day oral cefaclor for treating acute otitis media.
- This regimen offers comparable efficacy and may improve treatment adherence due to its single-dose administration.
Abstract:
We conducted a controlled clinical trial to determine the efficacy of single-dose intramuscular ceftriaxone for the treatment of acute otitis media. Fifty-four children aged 18 months to 6 years with clinical and tympanometric evidence of otitis media were randomized to receive either 50 mg/kg ceftriaxone or 10 days of oral cefaclor 40 mg/kg/day. Resolution of symptoms and clinical and tympanometric appearance of the tympanic membrane at follow-up visits were used to determine outcome. Thirty-one children received ceftriaxone and 23 received oral cefaclor. There were no treatment failures. There were no significant differences between groups in persistence of effusion or recurrence of acute otitis media. We conclude that a single intramuscular dose of ceftriaxone compares favorably with 10 days of oral cefaclor for the treatment of acute otitis media.